COMMENT ON ‘HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH’

2014 ◽  
Vol 23 (3) ◽  
pp. 374-375
Author(s):  
David Epstein
2012 ◽  
Vol 30 (34) ◽  
pp. 4194-4201 ◽  
Author(s):  
Olwen M. Hahn ◽  
Richard L. Schilsky

Comparative effectiveness research (CER) has been promoted as a way to improve the translation gap between clinical research and everyday clinical practice as well as to deliver more cost-effective health care. CER will account for a significant portion of funding allocated by the US government for health care research. Oncology has a rich history of improving clinical outcomes and advancing research through randomized controlled trials (RCTs). In this article, we review the role of RCTs in achieving the goals of CER, with particular emphasis on the role of publicly funded clinical trials.


2011 ◽  
Vol 14 (7) ◽  
pp. A487
Author(s):  
L. Varasteh ◽  
A. Pedan ◽  
E. Asumeng-Denteh

Author(s):  
Joe V. Selby ◽  
Evelyn P. Whitlock ◽  
Kelly S. Sherman ◽  
Jean R. Slutsky

Sign in / Sign up

Export Citation Format

Share Document